(Q36379383)

13 August 2017

1 reference

title

Adipose targets for obesity drug development (English)

1 reference

13 August 2017

0 references

Olivier Boss

1

1 reference

13 August 2017

Nils Bergenhem

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

Expert Opinion on Therapeutic Targets

13 August 2017

published in

1 reference

13 August 2017

volume

10

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

119-134

1 reference

Obesity-induced inflammatory changes in adipose tissue.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Calorie restriction in nonhuman primates: mechanisms of reduced morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

A role for suppressed skeletal muscle thermogenesis in pathways from weight fluctuations to the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

An adipose-specific control of thermogenesis in body weight regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Secretory factors from human adipose tissue and their functional role

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

21 January 2018

You are what you secrete

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Adipose tissue: new therapeutic targets from molecular and genetic studies--IASO Stock Conference 2003 report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Adipokines: molecular links between obesity and atheroslcerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Metabolic syndrome: a clinical and molecular perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Fat cells: afferent and efferent messages define new approaches to treat obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Role of adipocyte-derived factors in enhancing insulin signaling in skeletal muscle and white adipose tissue of mice lacking Acyl CoA:diacylglycerol acyltransferase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Two-dimensional electrophoresis of human placental mitochondria and protein identification by mass spectrometry: toward a human mitochondrial proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Use of mass spectrometry-derived data to annotate nucleotide and protein sequence databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Adipose tissue as an active endocrine organ: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Weight-reducing effects of the plasma protein encoded by the obese gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Effects of the obese gene product on body weight regulation in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Leptin and the regulation of body weight in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

The role of leptin resistance in the lipid abnormalities of aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Protein tyrosine phosphatase 1B negatively regulates leptin signaling in a hypothalamic cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

PTP1B regulates leptin signal transduction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

AdipoQ is a novel adipose-specific gene dysregulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Endogenous glucose production is inhibited by the adipose-derived protein Acrp30

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

The insulin-sensitizing role of the fat derived hormone adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Differential regulation of fatty acid trapping in mouse adipose tissue and muscle by ASP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Acylation stimulating protein and triacylglycerol synthesis: potential drug targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

PPAR gamma, 10 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

PPARs and the complex journey to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Peroxisome proliferator-activated receptor gamma: the more the merrier?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Metabolic syndrome targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

PPARs: therapeutic targets for metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Regulatory role of peroxisome proliferator-activated receptor delta (PPAR delta) in muscle metabolism. A new target for metabolic syndrome treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Regulation of muscle fiber type and running endurance by PPARdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Second-generation thiazolidinediones and hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Stearoyl-CoA desaturase-1 and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Obesity resistance and enhanced glucose metabolism in mice transplanted with white adipose tissue lacking acyl CoA:diacylglycerol acyltransferase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Protein tyrosine phosphatase 1B inhibitors for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

PTP1B antisense-treated mice show regulation of genes involved in lipogenesis in liver and fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Potentiation of insulin-related signal transduction by a novel protein-tyrosine phosphatase inhibitor, Et-3,4-dephostatin, on cultured 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Identification of a novel class of orally active pyrimido[5,4-3][1,2,4]triazine-5,7-diamine-based hypoglycemic agents with protein tyrosine phosphatase inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Discovery and Structure−Activity Relationship of Oxalylarylaminobenzoic Acids as Inhibitors of Protein Tyrosine Phosphatase 1B

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Molecular design and biological activities of protein-tyrosine phosphatase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Discovery of a novel protein tyrosine phosphatase-1B inhibitor, KR61639: potential development as an antihyperglycemic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Why do adipocytes make the beta 3 adrenergic receptor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Respective degree of expression of beta 1-, beta 2- and beta 3-adrenoceptors in human brown and white adipose tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Learning new tricks from old dogs: beta-adrenergic receptors teach new lessons on firing up adipose tissue metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

A transgenic model of visceral obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Overexpression of perilipin A and B blocks the ability of tumor necrosis factor alpha to increase lipolysis in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Modulation of hormone-sensitive lipase and protein kinase A-mediated lipolysis by perilipin A in an adenoviral reconstituted system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Metabolic adaptations in the absence of perilipin: increased beta-oxidation and decreased hepatic glucose production associated with peripheral insulin resistance but normal glucose tolerance in perilipin-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Development of the thyroid hormone receptor beta-subtype agonist KB-141: a strategy for body weight reduction and lipid lowering with minimal cardiac side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Interleukin 1 receptor antagonist. A new member of the interleukin 1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

White adipose tissue contributes to UCP1-independent thermogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Exercise in a pill: feasibility of energy expenditure targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Beta-adrenergic receptors and regulation of energy expenditure: a family affair

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Metabolic control through the PGC-1 family of transcription coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

The flip side: Identifying small molecule regulators of nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Millennium fat-cell lipolysis reveals unsuspected novel tracks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Transcriptional synergy and the regulation of Ucp1 during brown adipocyte induction in white fat depots

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

The effects of K-111, a new insulin-sensitizer, on metabolic syndrome in obese prediabetic rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Biochemical and morphological effects of K-111, a peroxisome proliferator-activated receptor (PPAR)alpha activator, in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

Lipolysis: pathway under construction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.1.119

10.1517/14728222.10.1.119

21 January 2018

Identifiers

DOI

1 reference

release_dwyaxvwspvg27jbvl6yfp2tt34

13 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dwyaxvwspvg27jbvl6yfp2tt34

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference